MedTrace Logo

Virtual Reality Based Mirror Therapy

NCT06152328 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2026-05-07

No results posted yet for this study

Summary

The aim of this study is to examine the effectiveness of 3D virtual reality assisted mirror therapy based rehabilitation applications compared to classical methods used in stroke rehabilitation.

Conditions

  • Stroke
  • Upper Extremity Paresis
  • Upper Extremity Paralysis

Interventions

OTHER

Virtual reality applications based on mirror therapy

Mirror therapy-based games will be played for 30 minutes every day for eight weeks, three days a week, for the VR group.

OTHER

Conventional treatment

Bobath therapy, walking exercises, upper extremity active exercises, and proprioceptive neuromuscular facilitation techniques will be applied three days a week for eight weeks.

OTHER

Mirror therapy

In conventional mirror therapy, the unaffected extremities of the individuals will be positioned outside the mirror, while the affected extremities will be placed inside the mirror so that the patient cannot see them. In this way, the image of the intact hand will be transferred to the affected side and activities will be performed three days a week for eight weeks.

OTHER

Placebo virtual reality

For 8 weeks, watching the uninteractive virtual environment

Sponsors & Collaborators

  • The Scientific and Technological Research Council of Turkey

    collaborator OTHER

  • Abant Izzet Baysal University

    lead OTHER

Principal Investigators

  • Ramazan Kurul, Ph.D · Abant Izzet Baysal University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-01
Primary Completion
2026-05-02
Completion
2026-06-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06152328 on ClinicalTrials.gov